XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Net Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenue $ 715,056 $ 455,827 $ 1,445,061 $ 1,141,986
Cost of goods sold 106,940 108,151 386,840 351,669
Gross profit 608,116 347,676 1,058,221 790,317
General and administrative expense 2,583,574 3,287,918 7,624,085 8,063,265
Operations expense 842,579 857,130 2,714,139 2,657,314
Sales and marketing expense 336,043 333,377 1,135,383 908,867
Loss on goodwill impairment 0 0 0 7,231,093
Loss on impairment of property and equipment 0 0 162,905 0
Total operating loss (3,154,080) (4,130,749) (10,578,291) (18,070,222)
Other income 47,838 63,047 118,618 146,524
Other expense (60,671) (2,001) (60,671) (5,207)
Gain on derivative instruments 3,463 10,219 11,724 107,381
Net loss $ (3,163,450) $ (4,059,484) $ (10,508,620) $ (17,821,524)
Net loss attributable to common shareholders per common shares-basic and diluted (in dollars per share) $ (0.78) $ (1.04) $ (2.63) $ (4.95)
Weighted average shared used in computation – basic and diluted (in shares) 4,031,356 3,919,203 3,998,887 3,602,515